CD44 and neoplasm: To confirm CD44 expression as a target for NIR-PIT and tumor cell killing effects by CD44-targeted NIR-PIT, flow cytometry and in vitro CD44-targeted NIR-PIT were performed in the three different types of tumor cells (Figure 1A–E).